Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Department of Anesthesia, Mansoura University Hospitals, Mansoura, Dakahlia, Egypt
Seoul National University Hospital, Seoul, Korea, Republic of
Hong Kong Children's Hospital, Hong Kong, Hong Kong
Hôpital Erasme, Brussels, Belgium
Departement d'anesthesie Hopital Armand Trousseau, Paris, France
Hôpital Universitaire des Enfants Reine Fabiola, Brussels, Belgium
zagazig University, Zagazig, Sarkia, Egypt
Xuanwu hospital, Beijing, Beijing, China
Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of
Peking Union Medical College Hospital, Beijing, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.